Literature DB >> 9660833

Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein.

T Habib1, J A Hejna, R E Moses, S J Decker.   

Abstract

Antibodies raised against the 51C/SHIP2 inositol polyphosphate 5'-phosphatase were used to examine the effects of growth factors and insulin on the metabolism of this protein. Immunoblot analysis revealed that the 51C/SHIP2 protein was widely expressed in fibroblast and nonhematopoietic tumor cell lines, unlike the SHIP protein, which was found only in cell lines of hematopoietic origin. The 51C/SHIP2 antiserum precipitated a protein of approximately 145 kDa along with an activity which hydrolyzed phosphatidylinositol 3,4, 5-trisphosphate to phosphatidylinositol 3,4-bisphosphate. Tyrosine phosphorylation of the 51C/SHIP2 protein occurred in response to treatment of cells with epidermal growth (EGF), platelet-derived growth factor (PDGF), nerve growth factor (NGF), insulin-like growth factor-1 (IGF-1), or insulin. EGF and PDGF induced transient tyrosine phosphorylation of 51C/SHIP2, with maximal tyrosine phosphorylation occurring at 5-10 min following treatment and returning to near basal levels within 20 min. In contrast, treatment of cells with NGF, IGF-1, or insulin resulted in prolonged tyrosine phosphorylation of 51C/SHIP2 protein, with 40-80% maximal phosphorylation sustained for up to 2 h following agonist treatment. The kinetics of activation of the Akt/PKB protein kinase by the various factors correlated well with the kinetics of tyrosine phosphorylation of 51C/SHIP2. EGF, NGF, and PDGF stimulated the association of 51C/SHIP2 protein with the Shc adapter protein; however, no Shc could be detected in 51C/SHIP2-immune precipitates from cells treated with IGF-1 or insulin. The data suggest that 51C/SHIP2 may play a significant role in regulation of phosphatidylinositol 3'-kinase signaling by growth factors and insulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660833     DOI: 10.1074/jbc.273.29.18605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.

Authors:  E Muraille; X Pesesse; C Kuntz; C Erneux
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

Review 2.  Insulin signaling and the regulation of glucose transport.

Authors:  Louise Chang; Shian-Huey Chiang; Alan R Saltiel
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

3.  SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.

Authors:  N Prasad; R S Topping; S J Decker
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.

Authors:  T Wada; T Sasaoka; M Funaki; H Hori; S Murakami; M Ishiki; T Haruta; T Asano; W Ogawa; H Ishihara; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 5.  INPPL1 gene mutations in opsismodysplasia.

Authors:  Anaïs Fradet; Jamie Fitzgerald
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

6.  Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia.

Authors:  Cori Feist; Paul Holden; Jamie Fitzgerald
Journal:  Clin Dysmorphol       Date:  2016-10       Impact factor: 0.816

7.  5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.

Authors:  V Taylor; M Wong; C Brandts; L Reilly; N M Dean; L M Cowsert; S Moodie; D Stokoe
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

9.  SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.

Authors:  Sylvie Giuriato; Xavier Pesesse; Stéphane Bodin; Takehiko Sasaki; Cécile Viala; Evelyne Marion; Joseph Penninger; Stéphane Schurmans; Christophe Erneux; Bernard Payrastre
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

10.  Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

Authors:  M Huber; C D Helgason; M P Scheid; V Duronio; R K Humphries; G Krystal
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.